Chapter 7 - Recent Progress In Antiepileptic Drug Research

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Annual Reports in Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0065-7743(08)61072-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles.

  1998cited by this paper
• 5-Aminomethylquinoxaline-2,3-diones. Part I: A novel class of AMPA receptor antagonists.

  1998cited by this paper
• N-(benzyloxycarbonyl)glycine esters and amides as new anticonvulsants.

  1998cited by this paper
• A new nonNMDA antagonist modifies the local cerebral glucose utilization in kainate-induced generalized seizure.

  1997cited by this paper
• Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy

  1997cited by this paper
• Phospholipase C isozymes selectively couple to specific neurotransmitter receptors

  1997cited by this paper
• Time course of alpha-fluorinated valproic acid in mouse brain and serum and its effect on synaptosomal gamma-aminobutyric acid levels in comparison to valproic acid.

  1997cited by this paper
• Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.

  1997cited by this paper
• Profile of SB‐204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures

  1997cited by this paper
• Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1.

  1997cited by this paper
• Anticonvulsant action of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline in immature rats: comparison with the effects on motor performance.

  1997cited by this paper
• Recent advances in the pharmacotherapy of epilepsy.

  1997cited by this paper
• Tiagabine exerts an anti-epileptogenic effect in amygdala kindling epileptogenesis in the rat.

  1997cited by this paper
• Changes in voltage-dependent calcium channel α1-subunit mRNA levels in the kindling model of epileptogenesis

  1997cited by this paper
• Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.

  1997cited by this paper
• Voltage-dependent calcium channels as targets for convulsant and anticonvulsant alkyl-substituted thiobutyrolactones.

  1997cited by this paper
• Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin.

  1997cited by this paper
• 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.

  1997cited by this paper
• Effects of L-701,324, a high-affinity antagonist at the N-methyl-D-aspartate (NMDA) receptor glycine site, on the rat electroencephalogram

  1997cited by this paper
• Newer Anticonvulsant Drugs

  1997cited by this paper
• Voltage‐Activated Calcium Channels: Targets of Antiepileptic Drug Therapy?

  1997cited by this paper
• Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam.

  1997cited by this paper
• The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability

  1997cited by this paper
• Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.

  1997cited by this paper
• Trans-2-en-valproic acid limits action potential firing frequency in mouse central neurons in cell culture.

  1997cited by this paper
• The effect of losigamone (AO‐33) on electrical activity and excitatory amino acid release in mouse cortical slices

  1997cited by this paper
• GABA and Epileptogenesis

  1997cited by this paper
• Lamotrigine Reduces Voltage‐Gated Sodium Currents in Rat Central Neurons in Culture

  1997cited by this paper
• GABAB Receptors

  1997cited by this paper
• Characterization of the binding of [3H]‐SB‐204269, a radiolabelled form of the new anticonvulsant SB‐204269, to a novel binding site in rat brain membranes

  1997cited by this paper
• Antiepileptic Effects of Tiagabine, a Selective GABA Uptake Inhibitor, in the Rat Kindling Model of Temporal Lobe Epilepsy

  1997cited by this paper
• 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.

  1997cited by this paper
• Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.

  1997cited by this paper
• Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells.

  1997cited by this paper
• Aroyl(aminoacyl)pyrroles, a new class of anticonvulsant agents.

  1997cited by this paper
• Conformational preference of the 6-acetyl group in novel anticonvulsant trans 4S-benzamido-benzo[b]pyran-3R-ols

  1997cited by this paper
• Investigation into the preferred conformation of gabapentin for interaction with its binding site on the α2δ subunit of a calcium channel

  1997cited by this paper
• 3α-Hydroxy-3β-(phenylethynyl)-5β-pregnan-20-ones: Synthesis and Pharmacological Activity of Neuroactive Steroids with High Affinity for GABAA Receptors

  1997cited by this paper
• Structure-activity studies of aryl-spaced decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists

  1997cited by this paper
• Chapter 4. The Metabotropic Glutamate Receptors

  1996cited by this paper
• Vincamine and vincanol are potent blockers of voltage-gated Na+ channels.

  1996cited by this paper
• Felbamate inhibits cloned voltage-dependent Na+ channels from human and rat brain.

  1996cited by this paper
• Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.

  1996cited by this paper
• Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionate Receptor Antagonists: Synthesis and Structure−Activity Relationships of 6-(1H-Imidazol-1-yl)- 7-nitro-2,3(1H,4H)-pyrido[2,3-b]pyrazinedione and Related Compounds

  1996cited by this paper
• Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor.

  1996cited by this paper
• Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor

  1996cited by this paper
• Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase.

  1996cited by this paper
• Basis of the antiseizure action of phenytoin.

  1996cited by this paper
• Drug therapy : antiepileptic drugs

  1996cited by this paper
• High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complex.

  1996cited by this paper
• The Clinical Pharmacokinetics of the Newer Antiepileptic Drugs

  1996cited by this paper
• Synthesis and evaluation of N-(phenylacetyl)trifluoromethanesulfonamides as anticonvulsant agents.

  1996cited by this paper
• The new generation of antiepileptic drugs: advantages and disadvantages.

  1996cited by this paper
• Competitive NMDA‐Receptor Antagonists, LY 235959 and LY 233053, Enhance the Protective Efficacy of Various Antiepileptic Drugs Against Maximal Electroshock‐Induced Seizures in Mice

  1996cited by this paper
• Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity.

  1996cited by this paper
• (Aryloxy)aryl semicarbazones and related compounds: a novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen.

  1996cited by this paper
• Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.

  1996cited by this paper
• Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.

  1996cited by this paper
• Anticonvulsant action of metabotropic glutamate receptor agonists in kindled amygdala of rats.

  1996cited by this paper
• High-affinity alpha-aminobutyric acid A/benzodiazepine ligands: synthesis and structure-activity relationship studies of a new series of tetracyclic imidazoquinoxalines.

  1996cited by this paper
• Synthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivatives.

  1996cited by this paper
• Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.

  1996cited by this paper
• New drugs for the treatment of epilepsy.

  1996cited by this paper
• 3-Phenyl-Substituted Imidazo[1,5-a]quinoxalin-4-ones and Imidazo[1,5-a]quinoxaline Ureas That Have High Affinity at the GABAA/Benzodiazepine Receptor Complex†

  1996cited by this paper
• Inhibition of N‐type calcium currents by lamotrigine in rat amygdalar neurones

  1996cited by this paper
• Modulation of seizure activity in mice by metabotropic glutamate receptor ligands.

  1996cited by this paper
• New antiepileptic drugs.

  1996cited by this paper
• Binding thermodynamics of 5-HT1A receptor ligands.

  1996cited by this paper
• Therapeutic Potential of AMPA Receptor Ligands in Neurological Disorders

  1996cited by this paper
• Metabotropic glutamate receptors: novel targets for drug development.

  1995cited by this paper
• Chapter 6. Recent Progress in Excitatory Amino Acid Research

  1994cited by this paper
• Chapter 2. Antianxiety Agents and Anticonvulsants

  1989cited by this paper
• [Epilepsy and antiepileptic drugs].

  1955cited by this paper

• In-silico Studies on Phthalimide GABA Analogs for Anticonvulsant Activity Against Sodium Channel and GABA-AT

  2023cites this paper
• Synthesis and Biological Activity Evaluation of Some New Coumarin Derivatives as Potent Anticonvulsant and CNS-Depressant Agents

  2022cites this paper
• Anticonvulsant Activities of Various Series of Heterocyclic Compounds Containing Triazole, Thiadiazine, Benzo-triazole, Benzothiazole, Oxadiazole Ring Systems

  2015cites this paper
• Design and synthesis of some new quinazolin-4-(3H)-ones as anticonvulsant and antidepressant agents

  2013cites this paper
• Synthesis and structure–activity relationship studies on novel 8-amino-3-[2-(4-fluorophenoxy)ethyl]-1,3-diazaspiro[4.5]decane-2,4-dione derivatives as anticonvulsant agents

  2013cites this paper
• New antiepileptic agents: structure–activity relationships

  2011cites this paper
• 5-HT2C receptor modulators: a patent survey

  2010cites this paper
• Synthesis of Some Oxime Ether Derivatives of 1‐(2‐Naphthyl)‐2‐(1,2,4‐triazol‐1‐yl)ethanone and Their Anticonvulsant and Antimicrobial Activities

  2006cites this paper
• Synthesis of Novel 3‐(Alkylcarbamoyl)‐2‐aryl‐1,2‐dihydro‐6,7‐(methylenedioxy)‐3H‐quinazolin‐4‐ones as Anticonvulsant Agents

  2006cites this paper
• Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs.

  2005cites this paper
• New anticonvulsant agents.

  2005cites this paper
• Investigation into new anticonvulsant derivatives of α-substituted N-benzylamides of γ-hydroxy- and γ-acetoxybutyric acid. Part 5: Search for new anticonvulsant compounds

  2004cites this paper
• INFLUENCE OF NEW-AMINOBUTYRIC ACID AMIDE DERIVATIVES AND ITS PHTHALIMIDE PRECURSORS ON THE CENTRAL NERVOUS SYSTEM ACTIVITY IN MICE

  2002cites this paper
• Synthesis and structure-activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores.

  2001cites this paper
• In silico studies for the rational discovery of anticonvulsant compounds.

  2000cites this paper